官方服务：
资源简介：
HBV preS regions from chronic hepatitis b patients
应用场景：
创建时间：
2017-12-20
相关数据集
CHB for Stepwise M2BPGi - Rev 1
This is the raw data from CHB patients who underwent blood profile tests, including M2BPGi. All data were from the Hasan Sadikin Chronic Hepatitis B Registry. Processed Data included.
DataCite Commons2024-08-11 更新170
Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B
Predicting hepatitis B surface antigen (HBsAg) clearance is important for chronic hepatitis B (CHB) patients receiving pegylated interferon-alfa (Peg-IFN) therapy. We aimed to determine the predictive
DataCite Commons2025-09-16 更新50
Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B
Predicting hepatitis B surface antigen (HBsAg) clearance is important for chronic hepatitis B (CHB) patients receiving pegylated interferon-alfa (Peg-IFN) therapy. We aimed to determine the predictive
Taylor & Francis Group2025-09-16 更新30
Supplementary Material for: A fatal outcome after cessation of nucleotide analogue therapy in a patient with chronic hepatitis B
Introduction: Emerging evidence suggest that long-term nucleotide analogue (NA) therapy can be ceased in a selective group of chronic hepatitis B (CHB). This is being gradually implemented in clinical
DataCite Commons2025-06-01 更新110
Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B.
Background & Aims A long immune-tolerant (IT) phase lasting for decades and delayed HBeAg seroconversion (HBe-SC) in patients with chronic hepatitis B (CHB) increase the risk of liver diseases. Ea
DataCite Commons2024-07-01 更新50
